Objective: We aimed to review the approaches of urologist and gynecologist in the management of overactivebladder (OAB).Material and methods: A questionnaire consisting of 12 items were answered by 375 urologist and 46 gynecologist.The differences between frequency of encountering OAB, their viewpoints concerning conservativetreatment, and their experience related to anticholinergic drug use and the management of refractoryOAB were compared.Results: The majority of the urologists, and gynecologists responded to the question “How often do youencounter OAB patients in your daily practice?” as ‘in 10-25, and 50% of our patients’, respectively (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: We aimed to review the approaches of urologist and gynecologist in the management of overactivebladder (OAB).Material and methods: A questionnaire consisting of 12 items were answered by 375 urologist and 46 gynecologist.The differences between frequency of encountering OAB, their viewpoints concerning conservativetreatment, and their experience related to anticholinergic drug use and the management of refractoryOAB were compared.Results: The majority of the urologists, and gynecologists responded to the question “How often do youencounter OAB patients in your daily practice?” as ‘in 10-25, and 50% of our patients’, respectively (
📊
Key Findings & Data:Objective: We aimed to review the approaches of urologist and gynecologist in the management of overactivebladder (OAB).Material and methods: A questionnaire consisting of 12 items were answered by 375 urologist and 46 gynecologist.The differences between frequency of encountering OAB, their viewpoints concerning conservativetreatment, and their experience related to anticholinergic drug use and the management of refractoryOAB were compared.Results: The majority of the urologists, and gynecologists responded to the question “How often do youencounter OAB patients in your daily practice?” as ‘in 10-25, and 50% of our patients’, respectively (
💡
Conclusion & Impact:Objective: We aimed to review the approaches of urologist and gynecologist in the management of overactivebladder (OAB).Material and methods: A questionnaire consisting of 12 items were answered by 375 urologist and 46 gynecologist.The differences between frequency of encountering OAB, their viewpoints concerning conservativetreatment, and their experience related to anticholinergic drug use and the management of refractoryOAB were compared.Results: The majority of the urologists, and gynecologists responded to the question “How often do youencounter OAB patients in your daily practice?” as ‘in 10-25, and 50% of our patients’, respectively (
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: We aimed to review the approaches of urologist and gynecologist in the management of overactivebladder (OAB).Material and methods: A questionnaire consisting of 12 items were answered by 375 urologist and 46 gynecologist.The differences between frequency of encountering OAB, their viewpoints concerning conservativetreatment, and their experience related to anticholinergic drug use and the management of refractoryOAB were compared.Results: The majority of the urologists, and gynecologists responded to the question “How often do youencounter OAB patients in your daily practice?” as ‘in 10-25, and 50% of our patients’, respectively (
Özet
Amaç: Bu çalışmada aşırı aktif mesanenin (AAM) yönetiminde ürolog ve jinekologların yaklaşımlarını gözden geçirmeyi amaçladık. Gereç ve yöntemler: On iki sorudan oluşan bir anket 375 ürolog ve 46 jinekolog tarafından cevaplandırıldı. AAM hastalarıyla karşılaşma sıklığı, konservatif tedavi hakkındaki görüşleri, antikolinerjik kullanımı ve refrakter AAM ile ilgili deneyimleri karşılaştırıldı. Bulgular: “Günlük pratiğinizde ne sıklıkla AAM hastalarıyla karşılaşıyorsunuz?” sorusuna ürologlar %10- 25 jinekologlar %50 cevabını verdi (
🔖
Cite This Article
DİNÇER, M., BAYRAK, Ö., COŞKUN, B., ÖNEM, K., ONUR, R., GÜRBÜZ, C. (2022). The attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey. Turkish Journal of Urology, Cilt: 43 - Sayı: 1, 68–74. https://ajindex.com/articles/614456
Phe V, de Wachter S, Roupret M, Chartier-Kastler E. How to define a refractory idiopathic overactive bladder? Neurourol Urodyn 2015;34:2-11. [CrossRef] Veenboer PW, Bosch JL. Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review. J Urol 2014;191:1003-8. [CrossRef] Wallace KM, Drake MJ. Overactive bladder. F1000 Res 2015;4. [CrossRef] Novara G, Galfano A, Secco S, D’Elia C, Cavalleri S, Ficarra V, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-63. [CrossRef] Hay-Smith EJ, Dumoulin C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2006:CD005654. [CrossRef] Tincello DG, Williams KS, Joshi M, Assassa RP, Abrams KR. Urinary diaries: a comparison of data collected for three days versus seven days. Obstet Gynecol 2007;109:277-80. [CrossRef] Agarwal A, Eryuzlu LN, Cartwright R, Thorlund K, Tammela TL, Guyatt GH, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol 2014;65:1211-7. [CrossRef] Abdel-Aziz KF, Lemack GE. Overactive bladder in the male patient: bladder, outlet, or both? Curr Urol Rep 2002;3:445-51. [CrossRef] Basu M, Duckett JR, Moran P, Freeman R. Clinicians’ views on the NICE guideline on the management of female urinary incontinence. J Obstet Gynaecol 2009;29:529-32. [CrossRef] Lucas MG, Bosch RJ, Burkhard FC, Cruz F, Madden TB, Nambiar AK, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol 2012;62:1130-42. [CrossRef Urinary Incontinence in Women: The Management of Urinary Incontinence in Women. National Institute for Health and Care Excellence: Clinical Guidelines. London 2013.
Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological A, Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015;193:1572-80. [CrossRef] Collins CW, Winters JC, American Urological A, Society of Urodynamics Female Pelvic M, Urogenital R. AUA/SUFU adult urodynamics guideline: a clinical review. Urol Clin North Am 2014;41:353-62. [CrossRef] Zumrutbas AE, Bozkurt AI, Tas E, Acar CI, Alkis O, Coban K, et al. Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: resu